ICU Medical’s (NASDAQ:ICUI) Q4 CY2025: Beats On RevenueMedical device company ICU Medical (
NASDAQ:ICUI) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, but sales fell by 13% year on year to $540.7 million. Its non-GAAP profit of $1.91 per share was 12.8% above analysts’ consensus estimates.
ICU Medical Announces Fourth Quarter 2025 Results and Provides Fiscal Year 2026 GuidanceSAN CLEMENTE, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended December 31, 2025.
What To Expect From ICU Medical’s (ICUI) Q4 EarningsMedical device company ICU Medical (
NASDAQ:ICUI)
will be reporting earnings this Thursday after the bell. Here’s what to expect.
Baxter International (BAX) Deep Dive: Navigating the 16% Plunge and a New Strategic EraOn February 16, 2026, the mood surrounding Baxter International (
NYSE: BAX) is one of cautious sobriety following a seismic shift in investor confidence. Long regarded as a defensive staple of the healthcare sector, Baxter recently saw its shares plummet by over 16% in a single trading session. This collapse followed a fourth-quarter 2025 earnings report [...]
1 of Wall Street’s Favorite Stock on Our Buy List and 2 We Find RiskyThe stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%.
But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
ICU Medical Announces Time of Fourth Quarter 2025 Earnings Conference CallSAN CLEMENTE, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its fourth quarter 2025 earnings release and conference call.
1 Cash-Producing Stock Worth Your Attention and 2 We Brush OffA company that generates cash isn’t automatically a winner.
Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
1 Russell 2000 Stock to Target This Week and 2 We Find RiskyThe Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential.
However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.
Baxter International (BAX) in 2025: A Deep Dive into the Transformation of a MedTech GiantAs of December 26, 2025, Baxter International Inc. (
NYSE: BAX) stands at a pivotal crossroads in its nearly century-long history. Long considered a defensive "blue-chip" staple of the healthcare sector, Baxter spent much of the early 2020s grappling with the massive debt from its $10.5 billion acquisition of Hillrom, supply chain fragilities exposed by the [...]
ICU Medical to Present at the 44th Annual J.P. Morgan Healthcare ConferenceSAN CLEMENTE, Calif., Dec. 31, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the 44th Annual J.P. Morgan Healthcare Conference being held in San Francisco, California, January 12-15, 2026. ICU Medical’s presentation will be on Wednesday, January 14, 2026 at 1:30 p.m. PT (4:30 p.m. ET). Company management will also be participating in one-on-one meetings on Wednesday, January 14, 2026.
3 Small-Cap Stocks We Think Twice AboutSmall-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings.
However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
1 of Wall Street’s Favorite Stock to Target This Week and 2 We QuestionThe stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%.
But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
3 Reasons to Sell ICUI and 1 Stock to Buy InsteadICU Medical trades at $148.44 per share and has stayed right on track with the overall market, gaining 11.4% over the last six months. At the same time, the S&P 500 has returned 13.1%.
1 Profitable Stock for Long-Term Investors and 2 We Brush OffNot all profitable companies are built to last - some rely on outdated models or unsustainable advantages.
Just because a business is in the green today doesn’t mean it will thrive tomorrow.
3 Low-Volatility Stocks We Find RiskyA stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance.
Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
3 Cash-Producing Stocks That Concern UsGenerating cash is essential for any business, but not all cash-rich companies are great investments.
Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Q3 Medical Devices & Supplies - Cardiology, Neurology, Vascular Earnings: ICU Medical (NASDAQ:ICUI) ImpressesAs the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at medical devices & supplies - cardiology, neurology, vascular stocks, starting with ICU Medical (
NASDAQ:ICUI).
1 Russell 2000 Stock on Our Watchlist and 2 We AvoidSmall-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names.
But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.
Myriad Genetics, Neogen, ICU Medical, HCA Healthcare, and Universal Health Services Stocks Trade Up, What You Need To KnowA number of stocks jumped in the afternoon session after reports revealed the Trump administration considered extending the Affordable Care Act (ACA) subsidies. These subsidies, which are government financial aids to help people pay for health insurance, are crucial for insurers as they maintain a stable customer base. An extension would ensure continued revenue for companies with significant exposure to the ACA marketplace. The news prompted a strong positive reaction from investors, with Centene (CNC) shares jumping as much as 8%, Molina Healthcare (MOH) rising over 3%, and Oscar Health (OSCR) soaring 18%. The potential for a two-year extension reduces regulatory uncertainty for the sector, which investors view as a significant positive for the industry's outlook.
Bruker, 10x Genomics, PacBio, ICU Medical, and Dentsply Sirona Shares Skyrocket, What You Need To KnowA number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a further adjustment” in the near term, sparking a significant market rally. Following his remarks, the probability of the central bank cutting rates at its December meeting jumped from 39% to over 73%, according to the CME FedWatch tool. This positive sentiment provided relief to markets amid concerns over high valuations, particularly in AI-related stocks.
ICU Medical to Participate at the Piper Sandler 37th Annual Healthcare ConferenceSAN CLEMENTE, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference being held in New York, December 2-4, 2025. ICU Medical’s fireside chat will be on Thursday, December 4, 2025 at 10:00 a.m. PT (1:00 p.m. ET). Company management will also be participating in one-on-one meetings on Thursday, December 4, 2025.
5 Insightful Analyst Questions From ICU Medical’s Q3 Earnings CallICU Medical’s third quarter results were met with a positive market response, as the company outpaced analyst expectations on both revenue and adjusted earnings. Management pointed to robust growth in its Consumables and IV Systems businesses, which offset reported revenue declines due to the deconsolidation of its IV Solutions segment. CEO Vivek Jain emphasized that strong customer implementations and progress in niche markets, alongside operational improvements, lifted margins and drove sequential earnings growth. The company also benefited from integration synergies and favorable settlements that enhanced gross margins.
1 Healthcare Stock with Impressive Fundamentals and 2 Facing HeadwindsPersonal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the industry to lag recently -
over the past six months, the collective 9.8% gain for healthcare stocks has fallen short of the S&P 500’s 17.2% rise.
ICU Medical (ICUI) Shares Skyrocket, What You Need To KnowShares of medical device company ICU Medical (
NASDAQ:ICUI)
jumped 7.7% in the afternoon session after the company reported third-quarter 2025 results that surpassed analyst expectations and provided an upbeat financial outlook.
